insights_auto
Why is MVIR down 5,56%?
Dive Deeperchevron_right
MVIR:STO
Medivir AB
1,46 SEK
arrow_downward
-5,56%(-0,086) 1D
8 ოქტ, 17:29:45 GMT+2 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MVIR...
Open
1,54 SEK
High
1,55 SEK
Low
1,45 SEK
Mkt. cap
914,08 მლნ.
Avg. vol.
1,48 მლნ.
Volume
3,06 მლნ.
52-wk high
2,88 SEK
52-wk low
0,34 SEK
EPS
-0,37 SEK
Shares outstanding
624,18 მლნ.
No. of employees
6
Open
1,54 SEK
High
1,55 SEK
Low
1,45 SEK
Mkt. cap
914,08 მლნ.
Avg. vol.
1,48 მლნ.
Volume
3,06 მლნ.
52-wk high
2,88 SEK
52-wk low
0,34 SEK
EPS
-0,37 SEK
Shares outstanding
624,18 მლნ.
No. of employees
6
News stories
From web sources and news partners
Business Insider
·
47 წუთის წინ
What I saw as David Ellison's Skydance rang the opening bell at the New York Stock Exchange
www.marketscreener.com
·
1 საათის წინ
Wah Fu Announces Corporate Name Change to Wah Fu Education & Technology Group Limited and Nasdaq Ticker “WAFU” Unchanged
24/7 Wall St.
·
18 წუთის წინ
Western Digital Crushed the S&P 500 Over 10 Years. Now AI Is Changing Everything
Reuters
·
2 საათის წინ
Wall St slips as higher yields and oil prices flag inflation risk
Profile
Medivir is a Swedish biotech company. Medivir focuses its research focus on oncology and particularly on innovative pharmaceuticals that meet substantial unmet medical needs. The pharmaceutical development work is conducted both in-house and through partnerships, usually with global pharmaceutical companies.
Medivir has a leading expertise in the design of protease inhibitors and in the science of nucleotides and nucleosides.
Medivir is listed on the Nasdaq Stockholm Mid Cap List.
In February 2020, Medivir announced that the company has signed a licensing agreement for Xerclear with Chinese company Shijiazhuang Yuanmai Biotechnology Co Ltd. The agreement gives SYB the right to register, manufacture and market the product in China. Wikipedia
About Medivir AB